Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Capital Employed (2024 - 2025)

CG Oncology's Return on Capital Employed history spans 2 years, with the latest figure at 0.26% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 8.0% year-over-year to 0.26%; the TTM value through Dec 2025 reached 0.26%, down 8.0%, while the annual FY2025 figure was 0.26%, 1.0% down from the prior year.
  • Return on Capital Employed reached 0.26% in Q4 2025 per CGON's latest filing, up from 0.26% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.15% in Q2 2024 to a low of 0.26% in Q3 2025.